Skip to content

Three Dividend Giants Deliver Decades of Growth—but Which Stock Wins?

From oil to healthcare, these dividend stalwarts reward investors—but only one boasts 240% stock gains. Which deserves your portfolio?

The image shows a poster with buildings in the background and a sky with clouds. The text on the...
The image shows a poster with buildings in the background and a sky with clouds. The text on the poster reads "Making the Wealthy Pay Their Fair Share".

Three Dividend Giants Deliver Decades of Growth—but Which Stock Wins?

Three long-standing dividend payers have shown remarkable consistency in rewarding shareholders. Exxon Mobil, Caterpillar, and Cardinal Health each boast decades of uninterrupted dividend growth. Yet their stock performances and analyst outlooks vary significantly.

Exxon Mobil holds the record for the longest streak of annual dividend increases among the three. The oil giant has raised its payout for 43 straight years, offering investors a forward annual dividend of $4.12. This translates to a yield of roughly 2.58%.

Caterpillar, meanwhile, has lifted its dividends for 32 consecutive years. Its forward annual dividend now stands at $6.04, yielding about 0.89%. The heavy machinery maker has also delivered strong returns, with its stock climbing 208% over the past five years. Analysts currently rate the stock a 'Moderate Buy,' forecasting potential upside of up to 22%. Cardinal Health has maintained dividend growth for over 25 years. The healthcare company's forward annual dividend is $2.04, yielding around 0.98%. Its stock performance outpaces the others, surging 240% in the last five years. Analysts view it even more favourably, with 16 rating it a 'Strong Buy' and predicting up to 33% upside.

While all three companies demonstrate reliability in dividend growth, their market performance and analyst sentiment differ. Exxon Mobil leads in dividend consistency, Caterpillar balances growth with moderate returns, and Cardinal Health stands out for its stock gains and strong analyst backing. Investors now have distinct options depending on their priorities.

Read also:

Latest